Up­dat­ed: FDA places par­tial hold on BioN­Tech-MediLink ADC af­ter mul­ti­ple deaths

The FDA placed an ear­ly-stage BioN­Tech tri­al on par­tial clin­i­cal hold af­ter re­searchers ob­served mul­ti­ple deaths, the com­pa­ny said in an …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.